Annual Net Income
-$20.84 M
+$33.38 M+61.57%
December 31, 2023
Summary
- As of February 7, 2025, LSTA annual net profit is -$20.84 million, with the most recent change of +$33.38 million (+61.57%) on December 31, 2023.
- During the last 3 years, LSTA annual net income has fallen by -$12.69 million (-155.71%).
- LSTA annual net income is now -190.69% below its all-time high of $22.98 million, reached on December 1, 2017.
Performance
LSTA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$4.93 M
+$114.00 K+2.26%
September 30, 2024
Summary
- As of February 7, 2025, LSTA quarterly net profit is -$4.93 million, with the most recent change of +$114.00 thousand (+2.26%) on September 30, 2024.
- Over the past year, LSTA quarterly net income has increased by +$435.00 thousand (+8.11%).
- LSTA quarterly net income is now -112.73% below its all-time high of $38.72 million, reached on June 1, 2017.
Performance
LSTA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$20.74 M
+$331.00 K+1.57%
September 30, 2024
Summary
- As of February 7, 2025, LSTA TTM net profit is -$20.74 million, with the most recent change of +$331.00 thousand (+1.57%) on September 30, 2024.
- Over the past year, LSTA TTM net income has increased by +$100.00 thousand (+0.48%).
- LSTA TTM net income is now -175.57% below its all-time high of $27.45 million, reached on March 1, 2018.
Performance
LSTA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LSTA Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +61.6% | +8.1% | +0.5% |
3 y3 years | -155.7% | +8.1% | +0.5% |
5 y5 years | -28.9% | +8.1% | +0.5% |
LSTA Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +61.6% | -22.4% | +86.8% | -3.4% | +63.1% |
5 y | 5-year | -155.7% | +61.6% | -174.7% | +86.8% | -186.2% | +63.1% |
alltime | all time | -190.7% | +74.2% | -112.7% | +86.8% | -175.6% | +74.4% |
Lisata Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$4.93 M(-2.3%) | -$20.74 M(-1.6%) |
Jun 2024 | - | -$5.04 M(-6.6%) | -$21.07 M(+5.1%) |
Mar 2024 | - | -$5.40 M(+0.7%) | -$20.05 M(-3.8%) |
Dec 2023 | -$20.84 M(-61.6%) | -$5.37 M(+2.0%) | -$20.84 M(-2.9%) |
Sep 2023 | - | -$5.26 M(+30.6%) | -$21.46 M(-59.9%) |
Jun 2023 | - | -$4.03 M(-34.9%) | -$53.59 M(-4.6%) |
Mar 2023 | - | -$6.19 M(+3.3%) | -$56.19 M(+3.6%) |
Dec 2022 | -$54.23 M(+97.4%) | -$5.99 M(-84.0%) | -$54.23 M(-1.5%) |
Sep 2022 | - | -$37.38 M(+464.2%) | -$55.03 M(+123.9%) |
Jun 2022 | - | -$6.63 M(+56.8%) | -$24.57 M(+4.0%) |
Mar 2022 | - | -$4.23 M(-37.8%) | -$23.63 M(-14.0%) |
Dec 2021 | -$27.47 M(+237.0%) | - | - |
Dec 2021 | - | -$6.79 M(-1.9%) | -$27.47 M(+5.2%) |
Sep 2021 | - | -$6.93 M(+21.9%) | -$26.10 M(+6.5%) |
Jun 2021 | - | -$5.68 M(-29.5%) | -$24.50 M(+100.5%) |
Mar 2021 | - | -$8.06 M(+48.5%) | -$12.22 M(+50.0%) |
Dec 2020 | -$8.15 M(-57.9%) | -$5.43 M(+2.0%) | -$8.15 M(+6.2%) |
Sep 2020 | - | -$5.33 M(-180.7%) | -$7.67 M(+5.9%) |
Jun 2020 | - | $6.60 M(-265.4%) | -$7.25 M(-61.8%) |
Mar 2020 | - | -$3.99 M(-19.5%) | -$18.98 M(-1.9%) |
Dec 2019 | -$19.36 M(+19.8%) | -$4.96 M(+1.2%) | -$19.36 M(+7.8%) |
Sep 2019 | - | -$4.90 M(-4.7%) | -$17.96 M(+8.1%) |
Jun 2019 | - | -$5.14 M(+17.7%) | -$16.61 M(+6.8%) |
Mar 2019 | - | -$4.37 M(+22.7%) | -$15.55 M(-3.8%) |
Dec 2018 | -$16.17 M(-170.4%) | -$3.56 M(+0.2%) | -$16.17 M(+4.5%) |
Sep 2018 | - | -$3.55 M(-12.9%) | -$15.47 M(+0.8%) |
Jun 2018 | - | -$4.08 M(-18.2%) | -$15.35 M(-155.9%) |
Mar 2018 | - | -$4.98 M(+74.0%) | $27.45 M(+19.0%) |
Dec 2017 | $22.98 M(-170.4%) | -$2.86 M(-16.5%) | $23.07 M(+15.5%) |
Sep 2017 | - | -$3.43 M(-108.9%) | $19.97 M(+20.9%) |
Jun 2017 | - | $38.72 M(-513.7%) | $16.52 M(-155.0%) |
Mar 2017 | - | -$9.36 M(+57.1%) | -$30.04 M(-8.0%) |
Dec 2016 | -$32.66 M(-59.6%) | -$5.96 M(-13.4%) | -$32.66 M(-45.5%) |
Sep 2016 | - | -$6.88 M(-12.2%) | -$59.89 M(-7.0%) |
Jun 2016 | - | -$7.83 M(-34.6%) | -$64.39 M(-12.6%) |
Mar 2016 | - | -$11.98 M(-63.9%) | -$73.68 M(-8.9%) |
Dec 2015 | -$80.89 M(+47.4%) | -$33.20 M(+191.8%) | -$80.89 M(+36.4%) |
Sep 2015 | - | -$11.38 M(-33.6%) | -$59.30 M(-8.6%) |
Jun 2015 | - | -$17.13 M(-10.7%) | -$64.90 M(+7.5%) |
Mar 2015 | - | -$19.19 M(+65.2%) | -$60.38 M(+10.0%) |
Dec 2014 | -$54.87 M(+40.8%) | -$11.61 M(-31.6%) | -$54.87 M(-1.7%) |
Sep 2014 | - | -$16.97 M(+34.7%) | -$55.80 M(+16.5%) |
Jun 2014 | - | -$12.61 M(-7.9%) | -$47.89 M(+9.2%) |
Mar 2014 | - | -$13.68 M(+9.2%) | -$43.86 M(+12.5%) |
Dec 2013 | -$38.98 M(-27.5%) | -$12.53 M(+38.2%) | -$38.98 M(-7.1%) |
Sep 2013 | - | -$9.07 M(+5.8%) | -$41.95 M(+1.6%) |
Jun 2013 | - | -$8.58 M(-2.6%) | -$41.29 M(-22.4%) |
Mar 2013 | - | -$8.80 M(-43.2%) | -$53.22 M(-1.0%) |
Dec 2012 | -$53.77 M(+14.1%) | -$15.51 M(+84.3%) | -$53.77 M(-5.9%) |
Sep 2012 | - | -$8.41 M(-59.0%) | -$57.11 M(+1.9%) |
Jun 2012 | - | -$20.51 M(+119.4%) | -$56.05 M(+21.5%) |
Mar 2012 | - | -$9.35 M(-50.4%) | -$46.15 M(-1.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | -$47.13 M(+102.2%) | -$18.85 M(+156.5%) | -$46.97 M(+36.9%) |
Sep 2011 | - | -$7.35 M(-30.7%) | -$34.30 M(+0.6%) |
Jun 2011 | - | -$10.61 M(+4.3%) | -$34.10 M(+18.1%) |
Mar 2011 | - | -$10.17 M(+64.6%) | -$28.87 M(+23.9%) |
Dec 2010 | -$23.31 M(-10.9%) | -$6.18 M(-13.5%) | -$23.31 M(-21.0%) |
Sep 2010 | - | -$7.14 M(+32.9%) | -$29.52 M(-0.3%) |
Jun 2010 | - | -$5.37 M(+16.5%) | -$29.60 M(+2.4%) |
Mar 2010 | - | -$4.61 M(-62.8%) | -$28.92 M(+10.5%) |
Dec 2009 | -$26.17 M(+183.2%) | -$12.39 M(+71.7%) | -$26.17 M(+61.5%) |
Sep 2009 | - | -$7.22 M(+53.9%) | -$16.21 M(+48.5%) |
Jun 2009 | - | -$4.69 M(+151.3%) | -$10.91 M(+27.1%) |
Mar 2009 | - | -$1.87 M(-23.2%) | -$8.58 M(-7.1%) |
Dec 2008 | -$9.24 M(-11.5%) | -$2.43 M(+26.5%) | -$9.24 M(+1.0%) |
Sep 2008 | - | -$1.92 M(-18.6%) | -$9.15 M(-20.8%) |
Jun 2008 | - | -$2.36 M(-6.5%) | -$11.56 M(+3.6%) |
Mar 2008 | - | -$2.53 M(+7.9%) | -$11.16 M(+6.8%) |
Dec 2007 | -$10.45 M(+72.6%) | -$2.34 M(-45.9%) | -$10.45 M(+4.9%) |
Sep 2007 | - | -$4.33 M(+121.0%) | -$9.96 M(+33.9%) |
Jun 2007 | - | -$1.96 M(+7.8%) | -$7.44 M(+10.6%) |
Mar 2007 | - | -$1.82 M(-2.2%) | -$6.73 M(+11.2%) |
Dec 2006 | -$6.05 M(+246.8%) | -$1.86 M(+2.8%) | -$6.05 M(+28.2%) |
Sep 2006 | - | -$1.81 M(+45.2%) | -$4.72 M(+35.3%) |
Jun 2006 | - | -$1.25 M(+9.3%) | -$3.49 M(+32.3%) |
Mar 2006 | - | -$1.14 M(+116.2%) | -$2.63 M(+51.0%) |
Dec 2005 | -$1.75 M(-0.2%) | -$527.00 K(-8.4%) | -$1.75 M(+15.0%) |
Sep 2005 | - | -$575.40 K(+46.4%) | -$1.52 M(+5.2%) |
Jun 2005 | - | -$393.10 K(+57.4%) | -$1.44 M(-6.4%) |
Mar 2005 | - | -$249.70 K(-16.6%) | -$1.54 M(-11.8%) |
Dec 2004 | -$1.75 M(+67.5%) | -$299.50 K(-40.2%) | -$1.75 M(-7.9%) |
Sep 2004 | - | -$500.50 K(+1.7%) | -$1.90 M(+18.5%) |
Jun 2004 | - | -$492.20 K(+7.9%) | -$1.60 M(+18.0%) |
Mar 2004 | - | -$456.20 K(+1.5%) | -$1.36 M(+30.0%) |
Dec 2003 | -$1.04 M(-10.0%) | -$449.60 K(+120.4%) | -$1.04 M(+7.5%) |
Sep 2003 | - | -$204.00 K(-17.6%) | -$971.00 K(-1.5%) |
Jun 2003 | - | -$247.60 K(+73.1%) | -$986.00 K(+1.3%) |
Mar 2003 | - | -$143.00 K(-62.0%) | -$973.00 K(-16.1%) |
Dec 2002 | -$1.16 M(-43.0%) | -$376.40 K(+71.9%) | -$1.16 M(-22.5%) |
Sep 2002 | - | -$219.00 K(-6.6%) | -$1.50 M(-8.7%) |
Jun 2002 | - | -$234.60 K(-28.9%) | -$1.64 M(-4.8%) |
Mar 2002 | - | -$329.80 K(-53.7%) | -$1.72 M(-15.3%) |
Dec 2001 | -$2.03 M(+0.3%) | -$712.50 K(+96.8%) | -$2.03 M(+9.6%) |
Sep 2001 | - | -$362.00 K(+13.9%) | -$1.86 M(-23.6%) |
Jun 2001 | - | -$317.80 K(-50.4%) | -$2.43 M(-2.1%) |
Mar 2001 | - | -$640.90 K(+19.9%) | -$2.48 M(+22.4%) |
Dec 2000 | -$2.03 M(+82.3%) | -$534.70 K(-42.9%) | -$2.03 M(+35.8%) |
Sep 2000 | - | -$935.70 K(+153.0%) | -$1.49 M(+168.0%) |
Jun 2000 | - | -$369.90 K(+97.9%) | -$556.80 K(+197.9%) |
Mar 2000 | - | -$186.90 K | -$186.90 K |
Dec 1999 | -$1.11 M(+148.5%) | - | - |
Dec 1998 | -$447.60 K(+69.6%) | - | - |
Mar 1998 | -$263.90 K(-20.7%) | - | - |
Mar 1997 | -$332.60 K(-119.4%) | - | - |
Mar 1996 | $1.71 M | - | - |
FAQ
- What is Lisata Therapeutics annual net profit?
- What is the all time high annual net income for Lisata Therapeutics?
- What is Lisata Therapeutics annual net income year-on-year change?
- What is Lisata Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly net income year-on-year change?
- What is Lisata Therapeutics TTM net profit?
- What is the all time high TTM net income for Lisata Therapeutics?
- What is Lisata Therapeutics TTM net income year-on-year change?
What is Lisata Therapeutics annual net profit?
The current annual net income of LSTA is -$20.84 M
What is the all time high annual net income for Lisata Therapeutics?
Lisata Therapeutics all-time high annual net profit is $22.98 M
What is Lisata Therapeutics annual net income year-on-year change?
Over the past year, LSTA annual net profit has changed by +$33.38 M (+61.57%)
What is Lisata Therapeutics quarterly net profit?
The current quarterly net income of LSTA is -$4.93 M
What is the all time high quarterly net income for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly net profit is $38.72 M
What is Lisata Therapeutics quarterly net income year-on-year change?
Over the past year, LSTA quarterly net profit has changed by +$435.00 K (+8.11%)
What is Lisata Therapeutics TTM net profit?
The current TTM net income of LSTA is -$20.74 M
What is the all time high TTM net income for Lisata Therapeutics?
Lisata Therapeutics all-time high TTM net profit is $27.45 M
What is Lisata Therapeutics TTM net income year-on-year change?
Over the past year, LSTA TTM net profit has changed by +$100.00 K (+0.48%)